FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2039745908> ?p ?o ?g. }

• W2039745908 endingPage "19457" @default.
• W2039745908 startingPage "19451" @default.
• W2039745908 abstract "Buthionine sulfoximine (BSO) is a synthetic amino acid that irreversibly inhibits an enzyme, γ-glutamylcysteine synthetase (γ-GCS), which is a critical step in glutathione biosynthesis. We isolated three BSO-resistant sublines, KB/BSO1, KB/BSO2, and KB/BSO3, from human epidermoid cancer KB cells. These cell lines showed 10-to 13-fold higher resistance to BSO, respectively, and had collateral sensitivity to cisplatin, ethacrynic acid, and alkylating agents such as melphalan and nitrosourea. Cellular levels of glutathione S-transferase π (GST-π) and its mRNA in BSO-resistant cell lines were less than 10% of the parental cells. Nuclear run-on assay showed that the transcriptional activity of GST-π was decreased in BSO-resistant cells, and transient transfection of GST-π promoter-chloramphenicol acetyltransferase constructs revealed that the sequences between −130 and −80 base pairs of the 5′-flanking region were at least partially responsible for the decreased expression of the GST-π gene. By contrast, γ-GCS mRNA levels were 3-to 5-fold higher in resistant cell lines than in KB cells, and the γ-GCS gene was found to be amplified in the BSO-resistant cell lines. GST-π mRNA levels appeared to be inversely correlated with γ-GCS mRNA levels in BSO-resistant cells. We further established the transfectants, KB/BSO3-π1 and KB/BSO3-π2, that overexpressed GST-π, from KB/BSO3, after introducing a GST-π expression plasmid. These two transfectants had similar levels in γ-GCS mRNA, drug sensitivity to alkylating agents, and glutathione content as those of KB cells. These findings suggest that the cellular levels of GST-π and γ-GCS might be co-regulated in these novel BSO-resistant cells. Buthionine sulfoximine (BSO) is a synthetic amino acid that irreversibly inhibits an enzyme, γ-glutamylcysteine synthetase (γ-GCS), which is a critical step in glutathione biosynthesis. We isolated three BSO-resistant sublines, KB/BSO1, KB/BSO2, and KB/BSO3, from human epidermoid cancer KB cells. These cell lines showed 10-to 13-fold higher resistance to BSO, respectively, and had collateral sensitivity to cisplatin, ethacrynic acid, and alkylating agents such as melphalan and nitrosourea. Cellular levels of glutathione S-transferase π (GST-π) and its mRNA in BSO-resistant cell lines were less than 10% of the parental cells. Nuclear run-on assay showed that the transcriptional activity of GST-π was decreased in BSO-resistant cells, and transient transfection of GST-π promoter-chloramphenicol acetyltransferase constructs revealed that the sequences between −130 and −80 base pairs of the 5′-flanking region were at least partially responsible for the decreased expression of the GST-π gene. By contrast, γ-GCS mRNA levels were 3-to 5-fold higher in resistant cell lines than in KB cells, and the γ-GCS gene was found to be amplified in the BSO-resistant cell lines. GST-π mRNA levels appeared to be inversely correlated with γ-GCS mRNA levels in BSO-resistant cells. We further established the transfectants, KB/BSO3-π1 and KB/BSO3-π2, that overexpressed GST-π, from KB/BSO3, after introducing a GST-π expression plasmid. These two transfectants had similar levels in γ-GCS mRNA, drug sensitivity to alkylating agents, and glutathione content as those of KB cells. These findings suggest that the cellular levels of GST-π and γ-GCS might be co-regulated in these novel BSO-resistant cells." @default.
• W2039745908 created "2016-06-24" @default.
• W2039745908 creator A5006400723 @default.
• W2039745908 creator A5015698845 @default.
• W2039745908 creator A5024688258 @default.
• W2039745908 creator A5034672583 @default.
• W2039745908 creator A5039250457 @default.
• W2039745908 creator A5082131946 @default.
• W2039745908 creator A5085314163 @default.
• W2039745908 date "1995-08-01" @default.
• W2039745908 modified "2023-10-16" @default.
• W2039745908 title "Markedly Decreased Expression of Glutathione S-Transferase π Gene in Human Cancer Cell Lines Resistant to Buthionine Sulfoximine, an Inhibitor of Cellular Glutathione Synthesis" @default.
• W2039745908 cites W129370812 @default.
• W2039745908 cites W133789967 @default.
• W2039745908 cites W1480389906 @default.
• W2039745908 cites W1504784308 @default.
• W2039745908 cites W1522785199 @default.
• W2039745908 cites W1523034549 @default.
• W2039745908 cites W1535345009 @default.
• W2039745908 cites W1535828429 @default.
• W2039745908 cites W1588826234 @default.
• W2039745908 cites W1589402586 @default.
• W2039745908 cites W1597236414 @default.
• W2039745908 cites W1660272883 @default.
• W2039745908 cites W1964223606 @default.
• W2039745908 cites W1966427723 @default.
• W2039745908 cites W1967692811 @default.
• W2039745908 cites W1973475159 @default.
• W2039745908 cites W1975384978 @default.
• W2039745908 cites W1990733040 @default.
• W2039745908 cites W1990775064 @default.
• W2039745908 cites W2012306261 @default.
• W2039745908 cites W2029678994 @default.
• W2039745908 cites W2031320828 @default.
• W2039745908 cites W2039331746 @default.
• W2039745908 cites W2042128008 @default.
• W2039745908 cites W2051099851 @default.
• W2039745908 cites W2071756286 @default.
• W2039745908 cites W2078374499 @default.
• W2039745908 cites W2078471960 @default.
• W2039745908 cites W2079476559 @default.
• W2039745908 cites W2091166505 @default.
• W2039745908 cites W2092449641 @default.
• W2039745908 cites W2095382516 @default.
• W2039745908 cites W2118519973 @default.
• W2039745908 cites W2323677697 @default.
• W2039745908 cites W2418841505 @default.
• W2039745908 cites W4245957869 @default.
• W2039745908 cites W4293247451 @default.
• W2039745908 cites W93439662 @default.
• W2039745908 doi "https://doi.org/10.1074/jbc.270.33.19451" @default.
• W2039745908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7642628" @default.
• W2039745908 hasPublicationYear "1995" @default.
• W2039745908 type Work @default.
• W2039745908 sameAs 2039745908 @default.
• W2039745908 citedByCount "29" @default.
• W2039745908 countsByYear W20397459082014 @default.
• W2039745908 countsByYear W20397459082015 @default.
• W2039745908 countsByYear W20397459082017 @default.
• W2039745908 crossrefType "journal-article" @default.
• W2039745908 hasAuthorship W2039745908A5006400723 @default.
• W2039745908 hasAuthorship W2039745908A5015698845 @default.
• W2039745908 hasAuthorship W2039745908A5024688258 @default.
• W2039745908 hasAuthorship W2039745908A5034672583 @default.
• W2039745908 hasAuthorship W2039745908A5039250457 @default.
• W2039745908 hasAuthorship W2039745908A5082131946 @default.
• W2039745908 hasAuthorship W2039745908A5085314163 @default.
• W2039745908 hasBestOaLocation W20397459081 @default.
• W2039745908 hasConcept C104317684 @default.
• W2039745908 hasConcept C150194340 @default.
• W2039745908 hasConcept C153911025 @default.
• W2039745908 hasConcept C161733203 @default.
• W2039745908 hasConcept C181199279 @default.
• W2039745908 hasConcept C2776907368 @default.
• W2039745908 hasConcept C2777476445 @default.
• W2039745908 hasConcept C2780730277 @default.
• W2039745908 hasConcept C538909803 @default.
• W2039745908 hasConcept C54009773 @default.
• W2039745908 hasConcept C54355233 @default.
• W2039745908 hasConcept C55493867 @default.
• W2039745908 hasConcept C81885089 @default.
• W2039745908 hasConcept C86803240 @default.
• W2039745908 hasConceptScore W2039745908C104317684 @default.
• W2039745908 hasConceptScore W2039745908C150194340 @default.
• W2039745908 hasConceptScore W2039745908C153911025 @default.
• W2039745908 hasConceptScore W2039745908C161733203 @default.
• W2039745908 hasConceptScore W2039745908C181199279 @default.
• W2039745908 hasConceptScore W2039745908C2776907368 @default.
• W2039745908 hasConceptScore W2039745908C2777476445 @default.
• W2039745908 hasConceptScore W2039745908C2780730277 @default.
• W2039745908 hasConceptScore W2039745908C538909803 @default.
• W2039745908 hasConceptScore W2039745908C54009773 @default.
• W2039745908 hasConceptScore W2039745908C54355233 @default.
• W2039745908 hasConceptScore W2039745908C55493867 @default.
• W2039745908 hasConceptScore W2039745908C81885089 @default.
• W2039745908 hasConceptScore W2039745908C86803240 @default.
• W2039745908 hasIssue "33" @default.
• W2039745908 hasLocation W20397459081 @default.

• next